Veeva Systems Inc. VEEV is well-poised for growth in the coming quarters, courtesy of its strong product portfolio. The ...

Veeva Systems (NYSE:VEEV) saw a 6% price increase last week, potentially influenced by the announcement of Tina Hunt's upcoming retirement from the board. This governance change may have reassured ...

We came across a bullish thesis on Veeva Systems Inc. (VEEV) on Substack by Francesco Ferrari. In this article, we will ...

Two years after first announcing the partnership, Boehringer Ingelheim and software firm Veeva Systems have launched ...

Boehringer Ingelheim and Veeva Systems (NYSE: VEEV) have announced the launch of Boehringer's One Medicine Platform, powered ...

Veeva released Q4 result on March 5 th, reporting 14.3% revenue growth and 28.7% adj. operating profit growth, as detailed in ...

Veeva Systems Inc. (NYSE:VEEV – Get Free Report) has been assigned a consensus rating of “Moderate Buy” from the twenty-five ...

Subscription services revenue rose to $608.6 million, marking a 16.7% year-over-year growth. Veeva Systems exceeded earnings expectations for Q4 2025, while demonstrating solid revenue growth and ...

Truist Financial analyst Jailendra Singh reiterated a Hold rating on Veeva Systems (VEEV – Research Report) today and set a price target of ...

NYSE:VEEV Earnings and Revenue History March 13th 2025 Zooming In On Veeva Systems' Earnings. In high finance, the key ratio used to measure how well a company converts reported p ...

Boehringer Ingelheim and Veeva Systems have announced the launch of Boehringer’s One Medicine Platform, powered by the successful implementation of Veeva Development Cloud. They ...

INGELHEIM, Germany and PLEASANTON, Calif., March 11, 2025 /PRNewswire/ -- Today, Boehringer Ingelheim and Veeva Systems (NYSE: VEEV) have announced the launch of Boehringer's One Medicine Platform ...